U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Details

Stereochemistry ACHIRAL
Molecular Formula C18H18FN3
Molecular Weight 295.354
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of CARVOTROLINE

SMILES

FC1=CC2=C(NC3=C2CN(CCC4=CC=NC=C4)CC3)C=C1

InChI

InChIKey=PMXOASNGMJAYTN-UHFFFAOYSA-N
InChI=1S/C18H18FN3/c19-14-1-2-17-15(11-14)16-12-22(10-6-18(16)21-17)9-5-13-3-7-20-8-4-13/h1-4,7-8,11,21H,5-6,9-10,12H2

HIDE SMILES / InChI

Description

Carvotroline [WY 47791] is a novel γ-carboline derivative with a preclinical profile suggestive of antipsychotic activity. Carvotroline has an affinity for the dopamine D2 receptor and cortical 5-HT2 receptor that is ten times greater than serotonin. Carvotroline administration to rats leads to a decrease of plasma corticosterone levels and demonstrated a moderating effect on the rotational-stress induced rise in plasma corticosterone levels.

Originator

Approval Year

PubMed

Patents

Sample Use Guides

In Vivo Use Guide
rat 7.0 mg/kg
Route of Administration: Intraperitoneal